Evolus (EOLS)
Evolus on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
6.4M
Short interest
settlement 2026-10-15
7.1
Days to cover
-2.3 days vs prior
77.1%
Short share of volume
2026-11-02
223
Fails to deliver
settlement 2026-10-13
Wed 4 Nov
Next earnings
estimated date
-$950K
Insider flow, 90 days
0 buys, 1 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in EOLS is 6,408,688 shares, up 877,929 shares over the last month. Over the last 48 readings it ranged from 5,184,738 shares (13 December 2024) to 13,478,555 shares (31 July 2025). At the reported average volume of 907K shares a day that is 7.1 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/eols" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 6,408,688 | +13.9% | 906,582 | 7.07 |
| 2026-09-30 | 5,628,168 | +1.8% | 603,494 | 9.33 |
| 2026-09-15 | 5,530,759 | +3.0% | 837,573 | 6.60 |
| 2026-08-31 | 5,368,957 | -8.3% | 1,029,865 | 5.21 |
| 2026-08-14 | 5,853,655 | +5.1% | 1,338,914 | 4.37 |
| 2026-07-31 | 5,568,442 | -5.7% | 637,372 | 8.74 |
| 2026-07-15 | 5,905,990 | -1.9% | 805,874 | 7.33 |
| 2026-06-30 | 6,018,141 | +2.1% | 824,575 | 7.30 |
| 2026-06-15 | 5,895,218 | -2.7% | 733,042 | 8.04 |
| 2026-05-29 | 6,059,626 | -1.8% | 741,098 | 8.18 |
| 2026-05-15 | 6,173,524 | -7.3% | 1,158,260 | 5.33 |
| 2026-04-30 | 6,656,973 | +0.6% | 751,207 | 8.86 |
| 2026-04-15 | 6,617,258 | +1.5% | 687,852 | 9.62 |
| 2026-03-31 | 6,517,006 | -14.4% | 992,379 | 6.57 |
| 2026-03-13 | 7,616,722 | -2.5% | 2,374,559 | 3.21 |
| 2026-02-27 | 7,807,678 | +0.1% | 473,807 | 16.48 |
| 2026-02-13 | 7,800,641 | +5.6% | 928,384 | 8.40 |
| 2026-01-30 | 7,389,047 | +7.6% | 1,288,510 | 5.73 |
| 2026-01-15 | 6,867,536 | +1.2% | 1,716,628 | 4.00 |
| 2025-12-31 | 6,785,638 | +6.9% | 807,907 | 8.40 |
| 2025-12-15 | 6,346,498 | -6.3% | 917,590 | 6.92 |
| 2025-11-28 | 6,770,213 | -40.0% | 1,186,705 | 5.71 |
| 2025-11-14 | 11,279,632 | -14.9% | 2,515,783 | 4.48 |
| 2025-10-31 | 13,255,815 | +0.1% | 973,009 | 13.62 |
| 2025-10-15 | 13,246,711 | +4.5% | 1,000,776 | 13.24 |
| 2025-09-30 | 12,682,534 | +8.8% | 1,132,483 | 11.20 |
| 2025-09-15 | 11,659,585 | +0.2% | 850,285 | 13.71 |
| 2025-08-29 | 11,632,162 | +8.9% | 977,266 | 11.90 |
| 2025-08-15 | 10,683,088 | -20.7% | 3,205,724 | 3.33 |
| 2025-07-31 | 13,478,555 | +6.7% | 984,374 | 13.69 |
| 2025-07-15 | 12,630,982 | +5.3% | 835,849 | 15.11 |
| 2025-06-30 | 11,995,910 | +13.1% | 936,335 | 12.81 |
| 2025-06-13 | 10,605,286 | +9.7% | 1,130,402 | 9.38 |
| 2025-05-30 | 9,665,285 | +4.7% | 1,137,148 | 8.50 |
| 2025-05-15 | 9,235,364 | +5.7% | 1,180,557 | 7.82 |
| 2025-04-30 | 8,735,496 | +13.9% | 781,431 | 11.18 |
| 2025-04-15 | 7,671,902 | +7.2% | 1,240,340 | 6.19 |
| 2025-03-31 | 7,154,927 | +1.5% | 589,350 | 12.14 |
| 2025-03-14 | 7,051,787 | +3.6% | 882,433 | 7.99 |
| 2025-02-28 | 6,806,832 | +3.8% | 493,201 | 13.80 |
| 2025-02-14 | 6,559,655 | +9.5% | 908,805 | 7.22 |
| 2025-01-31 | 5,989,260 | +1.0% | 1,011,095 | 5.92 |
| 2025-01-15 | 5,931,320 | +9.8% | 833,659 | 7.11 |
| 2024-12-31 | 5,400,784 | +4.2% | 569,405 | 9.48 |
| 2024-12-13 | 5,184,738 | -0.5% | 417,593 | 12.42 |
| 2024-11-29 | 5,210,222 | -1.5% | 627,953 | 8.30 |
| 2024-11-15 | 5,289,354 | -2.6% | 851,207 | 6.21 |
| 2024-10-31 | 5,433,370 | +9.0% | 475,303 | 11.43 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of EOLS volume is 77.1%, up 3.8 points over the last five sessions. Over the last 30 readings it ranged from 36.1% (28 October 2026) to 79.5% (30 October 2026). The latest reading sits at the top of that range. The latest reading is 13.7 points above the 30-session average of 63.4%, on 178K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 137K | 178K | 77.1% | 6 |
| 2026-10-30 | 149K | 188K | 79.5% | 7 |
| 2026-10-29 | 155K | 349K | 44.5% | 0 |
| 2026-10-28 | 105K | 291K | 36.1% | 484 |
| 2026-10-27 | 83K | 207K | 40.0% | 0 |
| 2026-10-26 | 85K | 116K | 73.4% | 0 |
| 2026-10-23 | 104K | 169K | 61.4% | 290 |
| 2026-10-22 | 100K | 217K | 46.1% | 2,551 |
| 2026-10-21 | 95K | 141K | 67.6% | 8 |
| 2026-10-20 | 72K | 115K | 62.9% | 14 |
| 2026-10-19 | 113K | 174K | 65.2% | 13 |
| 2026-10-16 | 131K | 260K | 50.5% | 4 |
| 2026-10-15 | 208K | 311K | 66.7% | 0 |
| 2026-10-14 | 210K | 327K | 64.2% | 0 |
| 2026-10-13 | 141K | 222K | 63.2% | 317 |
| 2026-10-12 | 337K | 440K | 76.5% | 4,000 |
| 2026-10-09 | 109K | 142K | 76.4% | 0 |
| 2026-10-08 | 143K | 218K | 65.7% | 12,929 |
| 2026-10-07 | 113K | 212K | 53.4% | 5 |
| 2026-10-06 | 108K | 192K | 56.3% | 8 |
| 2026-10-05 | 150K | 246K | 61.1% | 6,739 |
| 2026-10-02 | 509K | 723K | 70.4% | 7,983 |
| 2026-10-01 | 155K | 342K | 45.3% | 3,775 |
| 2026-09-30 | 107K | 148K | 72.2% | 12 |
| 2026-09-29 | 97K | 131K | 73.9% | 86 |
| 2026-09-28 | 80K | 111K | 72.0% | 12 |
| 2026-09-25 | 76K | 103K | 73.6% | 0 |
| 2026-09-24 | 58K | 83K | 70.0% | 0 |
| 2026-09-23 | 107K | 144K | 74.5% | 0 |
| 2026-09-22 | 91K | 144K | 63.6% | 16 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in EOLS is 223 shares, down 999 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (3 September 2026) to 19,712 shares (17 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 223 | $7.75 | $2K |
| 2026-10-09 | 1,222 | $7.80 | $10K |
| 2026-10-05 | 1,295 | $7.14 | $9K |
| 2026-09-17 | 19,712 | $7.99 | $157K |
| 2026-09-11 | 1,884 | $7.91 | $15K |
| 2026-09-08 | 1,005 | $9.30 | $9K |
| 2026-09-03 | 1 | $9.06 | $9 |
| 2026-08-28 | 214 | $8.88 | $2K |
| 2026-08-24 | 2,943 | $8.39 | $25K |
| 2026-08-20 | 515 | $8.60 | $4K |
| 2026-08-12 | 54 | $8.34 | $450 |
| 2026-07-28 | 2,757 | $6.18 | $17K |
| 2026-07-24 | 304 | $5.99 | $2K |
| 2026-06-26 | 2,782 | $7.15 | $20K |
| 2026-06-18 | 648 | $6.74 | $4K |
| 2026-06-04 | 1,374 | $6.03 | $8K |
| 2026-05-29 | 1,283 | $6.57 | $8K |
| 2026-05-15 | 538 | $6.58 | $4K |
| 2026-05-14 | 1,323 | $6.72 | $9K |
| 2026-05-13 | 228 | $6.50 | $1K |
| 2026-05-11 | 613 | $6.36 | $4K |
| 2026-05-08 | 2,945 | $6.39 | $19K |
| 2026-04-17 | 693 | $4.53 | $3K |
| 2026-04-14 | 223 | $4.33 | $966 |
| 2026-04-13 | 7,973 | $4.27 | $34K |
| 2026-04-02 | 79 | $4.31 | $340 |
| 2026-03-24 | 6,116 | $4.68 | $29K |
| 2026-03-12 | 69 | $5.39 | $372 |
| 2026-03-09 | 6,702 | $5.53 | $37K |
| 2026-02-13 | 27 | $4.28 | $116 |
Insider trades
SEC Form 4, newest first. JSONInsiders at EOLS reported 1 open-market sell worth $950K in the last 90 days and no open-market buys. Latest filing: MOATAZEDI DAVID (See Remarks) on 2026-09-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | MOATAZEDI DAVID | See Remarks | Sell | 105K | $9.04 | $950K | 500K |
| 2026-03-20 | MOATAZEDI DAVID | See Remarks | Sell | 14K | $4.75 | $65K | 605K |
| 2026-03-20 | Avelar Rui | See Remarks | Sell | 3K | $4.75 | $15K | 427K |
| 2026-03-17 | MOATAZEDI DAVID | See Remarks | Sell | 117K | $4.89 | $571K | 618K |
| 2026-03-17 | Avelar Rui | See Remarks | Sell | 30K | $4.89 | $147K | 431K |
| 2026-03-16 | MOATAZEDI DAVID | See Remarks | Exercise or conversion | 67K | $0.00 | $0 | 735K |
| 2026-03-16 | Avelar Rui | See Remarks | Exercise or conversion | 9K | $0.00 | $0 | 461K |
| 2026-02-17 | Parschauer Karah Herdman | Director | Grant | 46K | $0.00 | $0 | 78K |
| 2026-02-17 | Stewart Brady | Director | Grant | 46K | $0.00 | $0 | 134K |
| 2026-02-17 | Mitchell Tatjana | Chief Financial Officer | Grant | 121K | $0.00 | $0 | 226K |
| 2026-02-17 | White Albert G III | Director | Grant | 46K | $0.00 | $0 | 96K |
| 2026-02-17 | MOATAZEDI DAVID | See Remarks | Grant | 313K | $0.00 | $0 | 668K |
| 2026-02-17 | Malik Vikram | Director | Grant | 46K | $0.00 | $0 | 321K |
| 2026-02-17 | GILL DAVID N | Director | Grant | 46K | $0.00 | $0 | 87K |
| 2026-02-17 | Avelar Rui | See Remarks | Grant | 95K | $0.00 | $0 | 452K |
| 2025-12-22 | MOATAZEDI DAVID | See Remarks | Sell | 11K | $7.15 | $75K | 354K |
| 2025-12-22 | Avelar Rui | See Remarks | Sell | 2K | $7.15 | $16K | 357K |
| 2025-09-08 | Mitchell Tatjana | Chief Financial Officer | Grant | 105K | $0.00 | $0 | 105K |
| 2025-08-22 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | 6K | $7.51 | $43K | 90K |
| 2025-08-15 | Stewart Brady | Director | Buy | 30K | $6.82 | $204K | 89K |
| 2025-06-16 | MOATAZEDI DAVID | See Remarks | Sell | 17K | $9.89 | $164K | 365K |
| 2025-06-13 | MOATAZEDI DAVID | See Remarks | Sell | 111K | $10.05 | $1.1M | 382K |
| 2025-06-09 | White Albert G III | Director | Buy | 20K | $9.45 | $189K | 50K |
| 2025-05-13 | Beaver Sandra | Chief Financial Officer | Sell | 6K | $10.02 | $65K | 167K |
| 2025-05-12 | MOATAZEDI DAVID | See Remarks | Sell | 16K | $9.87 | $156K | 493K |
| 2025-05-12 | Avelar Rui | See Remarks | Sell | 3K | $9.87 | $33K | 359K |
| 2025-03-27 | MOATAZEDI DAVID | See Remarks | Sell | 6K | $12.40 | $78K | 509K |
| 2025-03-18 | MOATAZEDI DAVID | See Remarks | Sell | 103K | $13.26 | $1.4M | 515K |
| 2025-03-18 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | 5K | $13.26 | $60K | 96K |
| 2025-03-18 | Beaver Sandra | Chief Financial Officer | Sell | 9K | $13.26 | $119K | 174K |
| 2025-03-18 | Avelar Rui | See Remarks | Sell | 28K | $13.26 | $370K | 362K |
| 2025-03-12 | Parschauer Karah Herdman | Director | Sell | 13K | $12.99 | $167K | 32K |
| 2025-03-07 | Parschauer Karah Herdman | Director | Grant | 7K | $0.00 | $0 | 45K |
| 2025-03-07 | Malik Vikram | Director | Grant | 7K | $0.00 | $0 | 254K |
| 2025-03-07 | White Albert G III | Director | Grant | 7K | $0.00 | $0 | 30K |
| 2025-03-07 | Stewart Brady | Director | Grant | 7K | $0.00 | $0 | 59K |
| 2025-03-07 | GILL DAVID N | Director | Grant | 7K | $0.00 | $0 | 41K |
| 2025-03-07 | BLANK SIMONE | Director | Grant | 7K | $0.00 | $0 | 77K |
| 2025-03-07 | Avelar Rui | See Remarks | Grant | 24K | $0.00 | $0 | 390K |
| 2025-03-07 | MOATAZEDI DAVID | See Remarks | Grant | 95K | $0.00 | $0 | 618K |
| 2025-03-07 | Beaver Sandra | Chief Financial Officer | Grant | 36K | $0.00 | $0 | 183K |
| 2025-03-07 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Grant | 18K | $0.00 | $0 | 100K |
| 2024-12-23 | MOATAZEDI DAVID | See Remarks | Sell | 11K | $10.85 | $114K | 523K |
| 2024-12-23 | Beaver Sandra | Chief Financial Officer | Sell | 2K | $10.85 | $17K | 147K |
| 2024-12-23 | Avelar Rui | See Remarks | Sell | 2K | $10.85 | $24K | 367K |
| 2024-09-06 | Beaver Sandra | Chief Financial Officer | Sell | 3K | $14.98 | $49K | 149K |
| 2024-08-30 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | 6K | $15.85 | $89K | 82K |
| 2024-07-01 | White Albert G III | Director | Grant | 23K | $0.00 | $0 | 23K |
| 2024-06-06 | MOATAZEDI DAVID | See Remarks | Sell | 176K | $12.59 | $2.2M | 533K |
| 2024-06-06 | MOATAZEDI DAVID | See Remarks | Exercise or conversion | 176K | $7.28 | $1.3M | 709K |
| 2024-06-05 | MOATAZEDI DAVID | See Remarks | Exercise or conversion | 155K | $5.46 | $848K | 689K |
| 2024-06-05 | MOATAZEDI DAVID | See Remarks | Sell | 155K | $12.92 | $2.0M | 533K |
| 2024-06-04 | MOATAZEDI DAVID | See Remarks | Sell | 140K | $12.73 | $1.8M | 533K |
| 2024-06-03 | Malik Vikram | Director | Sell | 8K | $12.96 | $97K | 247K |
| 2024-05-14 | GILL DAVID N | Director | Sell | 7K | $12.60 | $85K | 34K |
| 2024-05-13 | Malik Vikram | Director | Sell | 28K | $12.93 | $362K | 254K |
| 2024-05-13 | GILL DAVID N | Director | Sell | 4K | $12.72 | $46K | 41K |
| 2024-05-10 | Beaver Sandra | Chief Financial Officer | Sell | 2K | $12.72 | $31K | 152K |
| 2024-05-10 | Avelar Rui | See Remarks | Sell | 3K | $12.72 | $44K | 369K |
| 2024-05-10 | MOATAZEDI DAVID | See Remarks | Sell | 16K | $12.72 | $204K | 674K |
| 2024-03-27 | MOATAZEDI DAVID | See Remarks | Sell | 6K | $13.86 | $86K | 690K |
| 2024-03-19 | MOATAZEDI DAVID | See Remarks | Sell | 97K | $13.92 | $1.3M | 696K |
| 2024-03-19 | Beaver Sandra | Chief Financial Officer | Sell | 6K | $13.92 | $79K | 154K |
| 2024-03-19 | Avelar Rui | See Remarks | Sell | 28K | $13.92 | $384K | 372K |
| 2024-02-22 | Beaver Sandra | Chief Financial Officer | Sell | 2K | $13.08 | $24K | 160K |
| 2024-02-22 | Avelar Rui | See Remarks | Sell | 2K | $13.08 | $24K | 400K |
| 2024-02-22 | MOATAZEDI DAVID | See Remarks | Sell | 8K | $13.08 | $101K | 792K |
| 2024-02-21 | Beaver Sandra | Chief Financial Officer | Grant | 13K | $0.00 | $0 | 162K |
| 2024-02-21 | Avelar Rui | See Remarks | Grant | 13K | $0.00 | $0 | 402K |
| 2024-02-21 | MOATAZEDI DAVID | See Remarks | Grant | 61K | $0.00 | $0 | 800K |
| 2024-02-07 | MOATAZEDI DAVID | See Remarks | Grant | 135K | $0.00 | $0 | 739K |
| 2024-02-07 | Avelar Rui | See Remarks | Grant | 35K | $0.00 | $0 | 389K |
| 2024-02-07 | Beaver Sandra | Chief Financial Officer | Grant | 35K | $0.00 | $0 | 149K |
| 2024-02-07 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Grant | 25K | $0.00 | $0 | 25K |
| 2024-02-07 | Malik Vikram | Director | Grant | 6K | $0.00 | $0 | 282K |
| 2024-02-07 | Parschauer Karah Herdman | Director | Grant | 6K | $0.00 | $0 | 38K |
| 2024-02-07 | HAYMAN ROBERT | Director | Grant | 6K | $0.00 | $0 | 55K |
| 2024-02-07 | Stewart Brady | Director | Grant | 6K | $0.00 | $0 | 51K |
| 2024-02-07 | GILL DAVID N | Director | Grant | 6K | $0.00 | $0 | 44K |
| 2024-02-07 | BLANK SIMONE | Director | Grant | 6K | $0.00 | $0 | 70K |
| 2024-01-30 | Parschauer Karah Herdman | Director | Sell | 12K | $13.14 | $157K | 31K |
| 2023-12-08 | MOATAZEDI DAVID | See Remarks | Sell | 31K | $9.73 | $305K | 604K |
| 2023-12-06 | MOATAZEDI DAVID | See Remarks | Sell | 51K | $10.09 | $518K | 635K |
| 2023-10-16 | Medytox Inc. | Other | Sell | 1.7M | $7.50 | $12.7M | 3.4M |
| 2023-09-06 | Beaver Sandra | Chief Financial Officer | Sell | 3K | $9.70 | $31K | 113K |
| 2023-08-21 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Grant | 63K | $0.00 | $0 | 63K |
| 2023-08-16 | MOATAZEDI DAVID | See Remarks | Sell | 15K | $10.27 | $152K | 687K |
| 2023-08-16 | Beaver Sandra | Chief Financial Officer | Sell | 2K | $10.27 | $23K | 117K |
| 2023-08-16 | Avelar Rui | See Remarks | Sell | 2K | $10.27 | $23K | 353K |
| 2023-08-15 | Malik Vikram | Director | Buy | 175K | $7.41 | $1.3M | 276K |
| 2023-08-14 | MOATAZEDI DAVID | See Remarks | Grant | 92K | $0.00 | $0 | 701K |
| 2023-08-14 | Beaver Sandra | Chief Financial Officer | Grant | 20K | $0.00 | $0 | 119K |
| 2023-08-14 | Avelar Rui | See Remarks | Grant | 20K | $0.00 | $0 | 356K |
| 2023-08-11 | HAYMAN ROBERT | Director | Other transaction | 218 | $0.00 | $0 | 48K |
| 2023-08-11 | HAYMAN ROBERT | Director | Other transaction | 366 | $0.00 | $0 | 10K |
| 2023-08-11 | BLANK SIMONE | Director | Other transaction | 115K | $0.00 | $0 | 483K |
| 2023-08-11 | BLANK SIMONE | Director | Other transaction | 109 | $0.00 | $0 | 63K |
| 2023-08-11 | Malik Vikram | Director | Other transaction | 23K | $0.00 | $0 | 101K |
| 2023-03-27 | MOATAZEDI DAVID | See Remarks | Sell | 6K | $8.47 | $52K | 610K |
| 2023-03-14 | Avelar Rui | See Remarks | Sell | 15K | $8.47 | $126K | 336K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for EOLS worth $950K at the prices reported; 1 in the last 90 days worth $950K. Latest: DAVID MOATAZEDI filed on 2026-09-02 to sell 105,108 shares ($950K) from 2026-09-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-02 | DAVID MOATAZEDIOfficer, Director | 105K | $950K | 0.159% | 2026-09-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON10 holders report 5% or more of EOLS in their latest filing, all on Schedule 13G (passive). The largest reported stake is Timothy P. Lynch at 9.9% of the class (6,425,726 shares), filed 2026-02-17 for an event on 2025-12-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-31 | 13G | Soleus Capital Master Fund, L.P.non-US institution | 3.5M | 5.3% | 2026-08-27 |
| 2026-08-31 | 13G | Soleus Capital, LLCother entity | 3.5M | 5.3% | 2026-08-27 |
| 2026-08-31 | 13G | Soleus Capital Group, LLCother entity | 3.5M | 5.3% | 2026-08-27 |
| 2026-08-31 | 13G | Soleus Capital Management, L.P.partnership | 3.5M | 5.3% | 2026-08-27 |
| 2026-08-31 | 13G | Soleus GP, LLCother entity | 3.5M | 5.3% | 2026-08-27 |
| 2026-08-31 | 13G | Guy Levyindividual | 3.5M | 5.3% | 2026-08-27 |
| 2026-03-26 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G/Ano. 2 | David Johnsonparent holding company, individual | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 2 | Caligan Partners LPinvestment adviser, partnership | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 4 | KEVIN TANGindividual | 1.2M | 1.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 4 | TANG CAPITAL MANAGEMENT, LLCother entity | 1.2M | 1.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 4 | TANG CAPITAL PARTNERS, LPpartnership | 620K | 1.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 4 | TANG CAPITAL PARTNERS INTERNATIONAL, LPpartnership | 546K | 0.8% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 4 | TANG CAPITAL PARTNERS III, INCcorporation | 73K | 0.1% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 4 | TANG CAPITAL PARTNERS IV, INCcorporation | 7K | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 2 | Timothy P. Lynchindividual | 6.4M | 9.9% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 1 | Daniel Mackparent holding company | 5.7M | 8.8% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Nantahala Capital Management, LLCinvestment adviser | 5.7M | 8.8% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Wilmot B. Harkeyparent holding company | 5.7M | 8.8% | 2025-09-30 |
13F holders
Tracked managers holding EOLS at their latest 13F. JSON6 of the 30 tracked managers held EOLS at their latest 13F, $31.5M in total at quarter-end prices. Millennium Management is the largest at $12.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 1.8M | $12.4M | 0.00% | +327K |
| Point72 Asset Management | 2026-06-30 | 1.5M | $10.5M | 0.01% | new |
| Citadel Advisors | 2026-06-30 | 506K | $3.5M | 0.00% | -190K |
| D. E. Shaw & Co. | 2026-06-30 | 337K | $2.3M | 0.00% | -222K |
| Renaissance Technologies | 2026-06-30 | 303K | $2.1M | 0.00% | -36K |
| AQR Capital Management | 2026-06-30 | 98K | $677K | 0.00% | +72K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Evolus in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Evolus (EOLS), SEC CIK 1570562, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-31.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 1570562Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of EOLS is sold short?
6,408,688 shares were held short at the 2026-10-15 settlement, 7.1 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is EOLS's daily short volume?
On 2026-11-02, 137,428 of the 178,127 EOLS shares reported to FINRA were sold short, 77.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does EOLS have fails to deliver?
The SEC's latest file shows 223 EOLS shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are EOLS insiders buying or selling?
Insiders at EOLS reported 1 open-market sell worth $950K in the last 90 days and no open-market buys. Latest filing: MOATAZEDI DAVID (See Remarks) on 2026-09-02.
Have EOLS insiders filed to sell?
1 Form 144 notice on file for EOLS worth $950K at the prices reported; 1 in the last 90 days worth $950K. Latest: DAVID MOATAZEDI filed on 2026-09-02 to sell 105,108 shares ($950K) from 2026-09-02.
Who owns 5% or more of EOLS?
10 holders report 5% or more of EOLS in their latest filing, all on Schedule 13G (passive). The largest reported stake is Timothy P. Lynch at 9.9% of the class (6,425,726 shares), filed 2026-02-17 for an event on 2025-12-31.
Which tracked 13F managers own EOLS?
6 of the 30 tracked 13F managers held EOLS shares at their latest filing, $31.5M in all. The largest: Izzy Englander's Millennium Management (1.8M shares, $12.4M), Steve Cohen's Point72 Asset Management (1.5M shares, $10.5M), Ken Griffin's Citadel Advisors (506K shares, $3.5M), D. E. Shaw & Co. (337K shares, $2.3M), Renaissance Technologies (303K shares, $2.1M), Cliff Asness's AQR Capital Management (98K shares, $677K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.